Open Your FREE Demat Account Now!

Indo US Bio-Tech Ltd. Share Price

NSE
BSE

NSE : INDOUS

BSE : 541304

Sector : Agri

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Low

₹64.15

High

₹68.50

Price Summary

Previous Close ₹66.55
Day's Range ₹64.15 - ₹68.50
Open ₹67.63
52 Week Range ₹57.50 - ₹159.00
Volume 4,143
Market Cap ₹0.00
Previous Close ₹66.88
Day's Range ₹64.11 - ₹68.49
Open ₹66.60
52 Week Range ₹60.00 - ₹158.85
Volume 348
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 2.73
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 26.49
TTM EPS (₹) 2.53
P/E Ratio 12.22
Book Value(₹) 0.00
PAT Margin (%) 10.11
Face Value (₹) 10.00
ROCE(%) 15.46
Trade Value ( ₹ in Lacs) 0.23
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 26.49
TTM EPS (₹) 2.53
P/E Ratio 12.22
Book Value(₹) 0.00
PAT Margin (%) 10.11
Face Value (₹) 10.00
ROCE(%) 15.46

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 308.47 1038.38
Expenses N/A N/A
PBT 35.59 165.3
Operating profit 0.0 0.0
Net profit 34.52 162.67

Shareholding Pattern

Promoters (% Holding)

68.29%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

31.70%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.01%

About Indo US Bio-Tech Ltd.

Founded 2004
Managing Director Jagdish Ajudia
NSE Symbol INDOUS

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Tata Consumer Products Ltd. 1,06,986.42 1,081.00 916.00 - 916.00
Balrampur Chini Mills Ltd. 13,933.44 658.35 393.55 - 393.55
CCL Products (India) Ltd. 13,085.07 979.00 885.70 - 885.70
E.I.D. - Parry (India) Ltd. 11,465.69 642.80 594.35 - 594.35
Gujarat Ambuja Exports Ltd. 6,992.43 152.85 102.05 - 102.05
Triveni Engineering & Industries Ltd. 5,283.20 240.00 220.05 - 220.05
Bajaj Hindusthan Sugar Ltd. 4,499.23 18.82 14.85 - 14.85
Shree Renuka Sugars Ltd. 3,914.29 18.39 17.14 - 17.14
Bannari Amman Sugars Ltd. 3,890.00 3,102.15 3,061.30 - 3,061.30
Dalmia Bharat Sugar And Industries Ltd. 3,722.40 458.50 261.40 - 261.40
no-content No Records Found

Latest News

Oct
31
2026
EQUITY Posted on Oct 31st 2026

Indo Us Bio Tech informs about newspaper advertisement

Indo Us Bio Tech has submitted the Newspaper Advertisement relating to the Unaudited quarterly & half yearly Standalone Financial Results for the quarter & Half year ended on 30th September, 2026 published in Western times - English and Western times - Gujarati Newspaper to comply Regulation 47 of SEBI LODR Regulations.

The above information is a part of company’s filings submitted to BSE.

Read More
Sep
5
2026
EQUITY Posted on Sep 5th 2026

Indo US Bio Tech informs about outcome of board meeting

Indo US Bio Tech has informed that the board met today, discussed and resolved following agendas: 1) Calling of Annual General Meeting (AGM) on Wednesday, 30th Day of September, 2026 at 02:30 PM through video conferencing (VC)/other Audio-Visual Means (OAVM) for the financial year ended on 31st March, 2026. 2) Approved the draft notice for calling 22nd Annual General Meeting. 3) Approved the draft of Directors’ Report for the financial year ended on 31st March, 2026. 4) Book Closure Date for the 22nd Annual General Meeting for F.Y. 2025-26 (Details as Annex A) 5) The e-voting period shall commence from Sunday, 27th September, 2026, 9:00 AM to Tuesday, 29th September, 2026, 5:00 PM. The remote e-voting module shall be disabled by NSDL after 5.00 PM on Tuesday, 29th September, 2026. The cut-off for determining the eligibility to vote is 23rd September, 2026 and only the persons holding shares of the Company (in physical or dematerialised form) on the cut-off date shall be entitled to avail the facility of remote e-voting and electronic voting through electronic Method at the Annual General Meeting (AGM) held through VC/ OAVM on 30th September, 2026. 6) Annual Report to be circulated to the Members of the Company (being Uploaded as Separate Attachment/ File) 7) Appointment of Bhagat & Associates, Chartered Accountants (FRN: 101100W) as a Statutory Auditors of the Company for a period of five consecutive years from the conclusion of the ensuing 22nd Annual General Meeting until the conclusion of the 27th Annual General Meeting, subject to the approval of the Members at the ensuing Annual General Meeting. After due consideration, the Board approved and recommended the appointment of Bhagat & Associates as the Statutory Auditors of the Company for consideration and approval of the Members at the ensuing 22nd Annual General Meeting. 8) Appoint Amrish Gandhi & Associates, Practising Company Secretary scrutinizer to scrutinize the e-voting process in a fair and transparent manner for the Annual General Meeting of the Company for the financial year ended on 31st March, 2026. 9) Any other business with the permission of the Board Chair. The Meeting commenced at 14:10 Hrs and concluded at 14:40 Hrs. 

The above information is a part of company’s filings submitted to BSE.

Read More
Nov
9
2026
EQUITY Posted on Nov 9th 2026

BN Agrochem informs about board meeting

Pursuant to Regulation 29(2) of the SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, BN Agrochem has informed that a meeting of the Board of Directors (‘the Board’) of the company (Formerly BN Holdings) will be held on Friday, November 13, 2026 to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the second quarter and half year ended September 30, 2026 along with the Limited Review Report of the Auditors for the corresponding period. With reference to its earlier letter dated September 23, 2026, the Trading Window, as per the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's code for Prevention of Insider Trading, is closed from October 01,2026 and would re-open after 48 hours from the date of announcement / declaration of Unaudited Standalone and Consolidated Financial Results for the second quarter and half-year ended September 30, 2026.
The above information is a part of company’s filings submitted to BSE. 
Read More
Nov
9
2026
EQUITY Posted on Nov 9th 2026

Neelamalai Agro Industries informs about board meeting

Neelamalai Agro Industries has informed that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 to consider and approve the Unaudited Financial Results of the Company for the second quarter and first half year ended 30th September 2026
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
7
2026
EQUITY Posted on Nov 7th 2026

Zeal Aqua informs about credit rating

Zeal Aqua has informed that Infomerics Valuation and Rating, vide its Press Release dated 06th November, 2026, has announced the rating action in respect of the Company's bank loan facilities aggregating to ₹226.00 Crore.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Indo US Bio-Tech Ltd. ?

The current share price of Indo US Bio-Tech Ltd. is ₹66.55 as of 2026-11-09.

The market capitalisation of Indo US Bio-Tech Ltd. is ₹134.11 as of 2026-11-09.

The 1-year return of Indo US Bio-Tech Ltd. is -65.12% as of 2026-11-09.

The P/E ratio of Indo US Bio-Tech Ltd. is 14.96 as of 2026-11-11.

The 52-week high and low of Indo US Bio-Tech Ltd. are ₹159.00 and ₹57.50, respectively, as of 2026-11-09.

The dividend yield of Indo US Bio-Tech Ltd. is 0.0% as of2026-11-09.

You can buy Indo US Bio-Tech Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Indo US Bio-Tech Ltd. is Jagdish Ajudia.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore